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Abstract: Engineered nanomaterials are emerging functional materials with 
technologically interesting properties and a wide range of promising applications, such as 
drug delivery devices, medical imaging and diagnostics, and various other industrial 
products. However, concerns have been expressed about the risks of such materials and 
whether they can cause adverse effects. Studies of the potential hazards of nanomaterials 
have been widely performed using cell models and a range of in vitro approaches. In the 
present review, we provide a comprehensive and critical literature overview on current  
in vitro toxicity test methods that have been applied to determine the mechanisms 
underlying the cytotoxic effects induced by the nanostructures. The small size, surface 
charge, hydrophobicity and high adsorption capacity of nanomaterial allow for specific 
interactions within cell membrane and subcellular organelles, which in turn could lead to 
cytotoxicity through a range of different mechanisms. Finally, aggregating the given 
information on the relationships of nanomaterial cytotoxic responses with an understanding 
of its structure and physicochemical properties may promote the design of biologically  
safe nanostructures. 
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1. Introduction 
The most common definition of nanotechnologies includes materials with at least one dimension in 
the range of 1 to 100 nm [1,2], although some authors classify them as all submicronic particles up to 
200 nm [3,4], or even up to 1000 nm [5,6]. At this size, nanomaterials (NMs) might interact in a 
unique fashion with biological systems and be easily taken up by cells [7], which opens up a wide 
range of interesting applications in medicine [8]. However, the same characteristics that make the NMs 
a promising approach for many new clinical therapies also make them very reactive structures that can 
generate undesirable cell interactions and adverse effects.  
Similarly, nanotechnologies may change many sectors of industry for the better, though 
considerable concern has arisen in these different industrial fields about their side effects and possible 
risks to human life. It is clear that the potential toxicity of nanoparticles (NPs) versus biological 
systems has to be much more thoroughly investigated than has been done to date in order to define 
their future role in clinical, diagnostic, technological and environmental applications. 
Concerning the unique properties of the NMs, a new research field of toxicology, namely 
nanotoxicology, was defined to address gaps in knowledge and also to assess the problems likely to be 
caused by nano-sized materials [9]. More specifically, nanotoxicology aims to understand the 
principles and mechanisms of interactions at the nano–bio interface and also to determine the 
relationship between NM physicochemical properties and the associate toxicological profiles [10]. It is 
a fact, with open discussions in the scientific community, that NM composition, size, geometry, and 
transport or durability in the body, can cause adverse effects on human health. Furthermore, due to 
their specific intrinsic properties, the NMs have a big tendency to suffer cellular uptake, which may 
also result in bioaccumulation and, thus, in increasing the adverse effects and toxic potential [11]. 
Moreover, it is widely described that NMs presented great chemical reactivity, which may lead to 
many kinds of toxic reactions, including mutagenicity by formation of DNA adducts or sensitization 
by hapten binding [1]. 
For most engineered NMs, toxicity data are unavailable or the data reported show very 
controversial and inconclusive results [1]. In such a context, an understanding of the toxicity 
mechanisms is crucial for both the design of more efficient NMs, and at the same time for the design 
of nanotechnologies that are biologically and/or environmentally benign throughout their life-cycle.  
Although numerous in vitro nanotoxicity studies have already been published, most of the 
experiments carried out thus far have used particles not well characterized regarding their composition 
and physicochemical properties. However, such a characterization is mandatory since nanoparticles 
might interact with assay components or interfere with detection systems resulting in unreliable data. 
Aspects related to the importance of a detailed characterization of the NMs prior to any in vitro studies 
are also reviewed and commented in this article in Section 3. 
A wide range of in vitro approaches has been used to assess the toxicological behavior of different 
types of NMs. However, many traditional approaches might have even greater limitations for NP than 
for other conventional chemicals and also may not offer the throughput and velocity to handle the 
dynamic developments in nanotechnologies [1]. Therefore, it is worth mentioning that novel 
approaches need to be developed in order to cover the needs of nanotoxicology. 
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The issue of safety and risk assessment of NMs becomes complicated because they are not a 
uniform group of substances [12,13]. Therefore, a huge problem concerning the toxicological aspects 
of NMs is the wide range of nanotechnologies with different chemical compositions, overall 
physicochemical characteristics and sizes. Along these lines, emerging information on quantitative 
structure–activity relationship (QSAR) modeling of NMs’ toxic effects is gaining force toward the 
construction of a database platform including the toxicological information of different NMs, 
interrelated with the physicochemical characteristics and chemical composition of each NM. The 
application of a structure–activity paradigm to NMs represents a promising approach to anticipate their 
toxicological properties in a fast and inexpensive way. Likewise, following this paradigm, it is possible 
to predict the toxic effects induced by NMs on the basis of some structural similarities with chemicals 
for which toxicological behavior have been previously determined [14]. 
Up until now, no NM-specific risk assessment paradigms have been produced, and therefore, 
researchers took liberal approaches to studying its toxicity [8,15]. For example, within the European 
Union, REACH (Registration, Evaluation, Authorisation and Restriction of Chemical substances) is for 
the time being the basis of NM risk assessment, even though no specific legislation is assigned 
specifically to NM analysis [16]. The regulatory agencies continuously reported that efforts to address 
the human toxicity of NMs should be directed towards developing models that predict associations 
between changes to NM physicochemical characteristics and hazardous properties [17]. Following this 
line, high throughput in vitro cellular models have been receiving growing attention toward 
establishment of rapid and reliable approaches for nanotoxicology assessments.  
Considering the special properties of NMs that can lead to toxic effects, many strategies  
have been applied to improve performance and reduce toxicity of NMs in medical design, i.e., the use 
of coating materials and/or the development of biocompatible/biodegradable NPs [18]. Independently 
of the approach used to design a new drug delivery system, its toxicological properties must be 
assessed by using, for example, in vitro cellular models for a primary screening and also for the 
elucidation of some inherent mechanism underlying toxicity of each type of nanodevice. There is 
growing concern regarding the interrelationship between particle size, shape, chemical composition 
and toxicological effects of NMs, which are demonstrated by the increasing number of studies 
considering this subject [19,20]. 
As already highlighted, the number of research articles concerning nanotoxicology has been 
growing significantly in the last decade. However, most of the data published is related to toxicological 
phenomena and the comprehension of the underlying mechanisms for NM-induced toxicity are less 
explored and understood. Therefore, the increasing usage of engineered NMs, especially in health 
concerns, has emphasized the need for further mechanistic insight to predict the consequences of 
exposure to this new class of materials. 
The characterization of the risks of the NMs is highly complex because of the special and specific 
physicochemical properties of such materials. In searching for a testing strategy that can rapidly and 
efficiently provide a screening approach for evaluating the potential hazard of NMs, researchers have 
been using a wide range of in vitro cellular models in an attempt to determine the toxicological 
behavior of NMs and to elucidate the mechanisms underlying this toxicity.  
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2. In Vitro Toxicity Assessment 
The wide variety of in vitro and in vivo assays that are employed to assess NP toxicity has been 
used because these are the tools that were already available for molecular toxicology when 
nanoparticle toxicity questions first arose. The first major problem with using these assays is that the 
modes of NP toxicity might not be the same as those incurred by molecular toxicants. Because of the 
expense of animal testing in toxicology and pressure from both the general public and government to 
develop alternatives to in vivo testing, in vitro cell-based approaches might be more attractive and 
necessary for NM toxicity assessment [21]. In vitro testing is a common first step in assessing the 
health risks related with engineered NMs. Despite the frequent lack of consistency or predictability 
between in vitro models and in vivo observations, there is little rational or ethical justification to 
proceed directly from material synthesis to animal models [22]. Moreover, some effects can be seen 
only in vitro and thus hazards that are masked by current in vivo tests due to animal defenses should 
not be underestimated [1]. Therefore, it is desirable to develop and validate simple non-in vivo assays 
for the purpose of predicting in vivo responses in order to reduce and avoid extensive testing using 
laboratory animals [23]. 
The primary focus of the in vitro assays is to assess the cytotoxic effects of chemicals and, more 
recently, of nano-based forms of such chemicals. However, the in vitro assays have many features and 
advantages to be used in more specific studies, i.e., to study the mechanisms underlying cytotoxicity 
induced by chemicals or NMs. In vitro approaches allowed researchers to obtain faster and more 
reliable mechanistic information on nanotoxicology. It is worth mentioning that the application of the 
in vitro methods to NMs do not follow a validated process. Hartung [1] described a number of 
alternative methods validated for chemicals and drugs that might be useful for NMs. Moreover, the 
author stated that efforts directed at the validation of the existing methods for NPs would not only 
expand the applicability domains of these validated methods, but might also allow a possible fast-track 
to obtaining regulatory acceptance for NP evaluation.  
On the other hand, there are some concerns about the growing use of in vitro methods for 
nanotoxicity assessments. Discussions are constantly raised about the fact that such alternative 
methods are less applicable to particles than to soluble chemical substances, mainly due to their 
particularly physicochemical properties. Indeed, some of these concerns apply to NM structure and 
characteristics, e.g., the in vitro kinetics of particles (their behavior in cell culture) might differ, 
including in terms of phenomena such as particle aggregation, binding to plastic and/or floating on the 
cell culture media surface [15,24]. Similarly, air exposure and specific artifacts used in cytotoxicity 
assays (i.e., MTT or NR dyes) might interfere in the in vitro experiments [1,25,26]. In this case, 
intrinsic photometric absorbance or fluorescence of NMs may alter colorimetric or fluorometric assay 
reporting. Moreover, the high surface energy and surface area of NMs may also contribute to the 
binding of unanticipated amounts of assay reagent or analyte [22]. However, the nanotoxicology is a 
new subject that is likely a driving force and not a declining influence regarding the use of modern 
approaches in toxicology [1,27,28]. In vitro methods have many advantages over the in vivo 
experiments, especially concerning the comprehension of the mechanisms underlying the toxic effects 
of NMs.  
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There are some authors that believe the first approach to proceed with a toxicological assessment of 
NMs is to use acellular systems to explore the reactivity of the materials in such acellular 
environments [23,29,30]. NMs that do not produce reactive species are seen as having a lower capacity 
for inducing significant toxic responses in biological systems. After this initial characterization, it 
would be possible to proceed to in vitro cellular models by using testing methods with relevant 
endpoints such as cytotoxicity, apoptosis, cell-cycle alterations, skin and ocular toxicity, genotoxicity, 
potential carcinogenicity and effects on the immunological system [13]. The underlying mechanisms 
of toxicity for NMs are remarkably complicated, hence the need for dedicated and specific analytical 
methodology and tools. 
Interestingly, many of the research articles that consider the mechanisms underlying cytotoxicity, 
using specifically in vitro assays, have focused on more than one mechanism of cell  
interaction [20,31]. This is important in order to obtain some correlation between each cell disturbance 
effect and also to determine a sequence of mechanisms and specific NM–cell interactions that would 
ultimately to toxic effect.  
Despite the great importance and validity of the in vitro model to screen compounds and identify 
the type of effect induced on cells, it is necessary to recognize that they may not be sufficient for 
defining safe exposure limits [32]. Simple in vitro methods are totally relevant for initial toxicity 
screening studies of NMs, as well as determining some mechanisms underlying cell interaction that 
may be responsible for their cytotoxicity. However, more physiologically relevant in vitro models or 
even in vivo assays might be useful and necessary to better understand how NMs can impact human 
health at all. 
2.1. Cytotoxicity Activity 
2.1.1. Cytotoxicity Assays 
The cytotoxicity data of most of the tested NMs have been generated by using tetrazolium  
salt-based endpoints. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT),  
3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxylmethoxyphenyl)-2-(4-sulfonyl)-2H-tetrazolium) (MTS), 
2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) (XTT), and the water-soluble 
tetrazolium salts (WST-8 and WST-1) assays are widely reported in the literature with this purpose.  
The MTT approach is the most common assay, and has been extensively applied to assess the effect 
of a variety of NMs on cell viability [7,31,33–38]. This method measures the reduction of MTT salt to 
a colored insoluble formazan in active mitochondria in viable cells [39]. Moreover, this assay can be 
applied either for cytotoxicity and cell proliferation studies. 
The cytotoxicity endpoint MTS was applied for monitoring the cytotoxic responses of gold  
NPs [40] and of cationic polystyrene nanosphere [41]. Moreover, MTS was also applied to determine 
the cell damage induced by bioadhesivepoly(anhydride) NPs destined for oral antigen/drug delivery. 
HepG2 and Caco-2 were used as model cell lines, the last one also being used in studies to 
discriminate between cytoadhesion and cytoinvasion mechanisms of cell interaction [42].  
Although to a lesser extent, the XTT assay has also been applied, e.g., to assess the cytotoxicity of 
citrate stabilized gold NPs in three cell lines [43] and of bio-active silica NPs in 19 different cell lines 
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representing all major organ types [44]. Specifically, in the later study, the results revealed little 
toxicity in any cell type analyzed and, therefore, the cell line characteristics did not influence the final 
toxic response. However, many authors have demonstrated that the organ and species of cell used in 
the cytotoxicity study have strong effects on the outcoming results [31,33,45]. The single 
characteristics of each cell line can make it less or more sensitive to the cytotoxic effects of a NM. As 
a general rule, the selection of a relevant cell type depends on the expected in vivo target organ and 
application of the NPs. 
The WST assays have appeared to be advantageous over MTT in that they are reduced outside cells, 
and yield a yellow-colored water-soluble formazan, which is soluble in the tissue culture medium. 
WST-8 assay was conducted to determine the cytotoxic potential of two-dimensional carbon-based 
NMs, including graphene sheets (GS) and graphene oxide (GO) [38], as well as to measure metabolic 
activity of six cell lines from different organs and species after exposure to silica NPs [45], and carbon 
black (CB), single-wall carbon nanotube, silicon dioxide (SiO2) and zinc dioxide (ZnO) NPs [19]. In 
another study, WST-8 endpoint was used to evaluate the cell proliferation of hepatic stellate cells 
(HSCs) treated with silver NPs [46]. Likewise, WST-1 derived assay is also a colorimetric technique 
that allows the quantitative determination of cell viability. It was used by Ghosh et al. [37] to 
determine the cytotoxicity of TiO2. 
The neutral red uptake assay (NRU) is also a simple endpoint commonly used to evaluate the 
cytotoxicity of different NMs [7,20,36,37]. It measures the uptake of the NR dye by viable cells with 
intact plasma membrane, and its concentration in lysosomes. 
Trypan blue staining is a dye exclusion assay, used to measure cell membrane integrity, and has 
been applied to determine the effects of gold [47] and TiO2 [37] NPs on cell membrane damage. 
Likewise, Nymark et al. [48] applied this simple cytotoxicity assay to determine the cytotoxicity of 
polyvinylpyrrolidone (PVP)-coated silver NPs by counting the number of living (unstained) cells using a 
phase-contrast microscopy. Moreover, Karlsson et al. [49] determined the potential of cooper-containing 
NPs to alter the cell membrane integrity by using this approach. Alternatively, these authors used the 
hemolytic assay and hemoglobin interactions to assess the particle–cell membrane interactions and, 
thus its cytotoxicity. Finally, Chueh et al. [40] counted trypan blue-stained cells (dead) on a hemocytometer 
under a microscope for the determination of cell growth curve after gold NPs treatment. 
Alternatively, cell membrane integrity can be assessed by monitoring the passage of substances that 
are normally sequestered inside cells to the outside, i.e., lactate dehydrogenase (LDH), which is 
commonly measured by the LDH leakage assay. This assay has been used in many kinds of studies on 
NM toxicity. Sun et al. [46] performed this assay to assess the acute toxicity of silver NPs on HSCs 
cells. Likewise, LDH release was measured to determine the cytotoxicity of cationic surfactant-based 
nanoparticles and micelles on neutrophils [50], and of multi-walled carbon nanotubes (MWCNTs) in 
four different cell lines [51]. 
Luminescent cell viability assay is another cytotoxicity assay employed in nanotoxicological 
studies, e.g., on PVP-coated silver NPs [48] and citrate stabilized gold NPs [43]. This assay determines 
the number of viable cells based on the quantification of ATP, which signals the presence of 
metabolically active cells. Darolles et al. [52] also performed intracellular ATP measurements to 
determine the cytotoxicity of cobalt oxide particles against cell metabolism. The authors used a 
commercial kit that measures the luminescence luciferase conversion to oxyluciferin. 
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Additionally, the resazurin (Alamar Blue) reduction assay, with fluorometric measurement, has 
been used to monitor toxic effects of NMs, i.e., of silver NPs [53], TiO2 NPs [37], ZnO NPs [54], and 
of multi-walled carbon nanotubes (MWCNTs) [51]. The number of viable cells correlates with the 
magnitude of dye reduction and, thus, also gives an overview of the cell’s metabolic condition.  
CBQCA total protein cell viability test is a specific assay that assesses the survival/viability and is 
based on the capacity of the cells to incorporate and bind a fluorescent dye (ATTO-TAG CBQCA) to 
the protein amines. Robbens et al. [8] used this approach to assess the effects of bio-active NPs and 
polyplexes on hepatocytes cell growth. A toxic chemical will result in a reduction of the growth rate as 
reflected by cell number, and this response is highlighted by the decrease of fluorescence of the amine 
bound CBQCA. 
Clonogenic assay were applied to count the colony numbers for determine cytotoxicity of gold NPs 
in two different studies [40,47]. Moreover, Darolles et al. [52] applied this assay to assess the 
cytotoxicity of cobalt oxide particles. In this assay, a colony is defined as at least 50 clones of one 
initial cell, and its count is performed through staining with crystal violet (0.5%). Besides, the cell 
growth assay, performed by using a Z1 counter, was applied to determine the effect of gold NPs on 
cytokinesis of three different cell lines [33]. Moreover, these authors used the colony-forming assays 
to determine the long-term cytotoxic of the same NPs.  
Another popular method is to stain the entire cell or specific cellular components with fluorescent dyes. 
This approach allows rapid detection via flow cytometry, and can be combined with microscopy-based 
analysis to evaluate, i.e., morphological features like cell spreading. In this line, viability measurements 
after zinc oxide NPs exposure have been performed using a mix of fluorescein diacetate (FDA) and 
ethidium bromide (EtBr) fluorescent dyes [55]. Cells were stained with a 1:1 solution of 80 μg/mL 
FDA plus 50 μg/mL EtBr and observed under a fluorescence microscope. In this double-staining 
method, living cells were stained in green, while dead cells exhibit their nucleus stained in orange. 
Furthermore, membrane integrity of human lung epithelial A549 cell line treated with engineered 
cadmium-coated silica NPs was assessed using calcein-AM/propidium iodide (PI) double-staining 
assay [56]. The cytotoxicity result was given after cell count using fluorescence microscopy. Likewise, 
quantification of cell viability was performed using PI and fluorescein diacetate (FdA) double staining 
after HeLa cells treatment with iron oxide magnetic NPs [57]. PI is normally excluded from the inside 
of healthy cells, but freely cross the membrane and stain intracellular components of cells with 
compromised membrane. The cells were analyzed by fluorescence microscopy and the cytotoxicity was 
established by the ratio between viable (green) and dead cells (red) counted on several microscopic 
fields. Some authors are also using commercial kits to determine the rate of cell proliferation after 
treatment with NPs. A cell proliferation assay based on the detection of fluorescence/red fluorescent 
dye that stains nucleic acids was used to determine the cytotoxicity of cobalt oxide particles [52]. 
A different approach based on a cell-culturing platform (Cell-IQ) has been used as a real-time  
cell-monitoring system to measure cell biological behaviors, including the total cell number, number of 
dead cells and cell movement. Sun et al. [46] applied this technology to study the behavior of HSCs 
cells after treatment with silver NPs. In this same line, an electrical measurement known as Electric 
Cell-Substrate Impedance Sensing (ECIS) was applied to real-time monitoring of in vitro cellular 
cytotoxicity of silica nanotubes [58] and gold NPs [47]. This technique has been used to study cellular 
viability and proliferation, and also has the advantages to be label-free and non-invasive in comparison 
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with other conventional viability assays. Likewise, real-time cell analysis (RTCA) system was used for 
continuous monitoring of changes in cell growth after treatment with gold NPs [40]. This system is 
also based on the measurement of cell impedance for continuous monitoring of cell growth.  
Recently, a new approach, called single-cell mechanics, which is derived from atomic force 
microscopy-based single-cell compression, has been proposed to investigate NM-induced cytotoxicity [59]. 
The authors proved the validity of this approach by reading force−deformation profiles following 
known NP treatments utilized previously. Moreover, it was highlighted that this single-cell-based 
approach is advantageous in terms of being able to directly correlate to in vivo investigations. 
Noteworthy is that the utilization of a simple in vitro endpoint can also give some valid information 
concerning the mechanisms underlying NM-induced cytotoxicity. For example, the widely used MTT 
assay measures the cell metabolic activity in the mitochondria of viable cells and can thus be used as a 
parameter to determine both cell metabolism and any damage to the mitochondrial compartments [20]. 
Moreover, the NRU assay reflects the functionality of the lysosomal membrane [60]. Finally, the LDH 
assay measures severe cell damage and is an indicator of plasma membrane integrity [19]. Therefore, 
due to their specific mechanisms, these different endpoints can display varied sensitivity to detect the 
cytotoxic effects of chemicals. The utilization of complementary assays in the same study, each one 
based on a different mechanism for toxicity detection, is therefore strongly recommended [61,62].  
Finally, it is known that NMs interfere with several assay systems, leading some researchers to 
dedicate efforts to understanding the specific behavior of different NMs with cell viability endpoints. 
Monteiro-Riviere et al. [26] reported that aluminum NPs interact with the MTT assay, and to a lesser 
extent, with CellTiter 96® AQueous One (96 AQ; Promega Corp, Madison, WI, USA) and Alamar 
blue® (aB; Invitrogen, Carlsbad, CA, USA) viability assays. Likewise, it was demonstrated that 
carbon-based NPs interacted with some widely used viability assays, including Alamar blue, NRU and 
MTT [25]. These interactions led to an apparent increase in viability and thus to a misinterpretation of 
the cytotoxicity data, which highlighted the importance of the combination of more than one assay when 
determining NP toxicity for risk assessment. Recently, Guadagnini et al. [63] published a specific study 
on the interferences of NMs with assay processes and components of classic in vitro tests. The authors 
have provided a great overview of the main challenges of the conventional viability assays when 
applied to nanostructures. 
2.1.2. Three-Dimensional (3D) Cell Culture Systems 
Clinically relevant in vitro models, such as the 3D cell culture systems, have been manufactured to 
mimic the properties of tissue in vivo. Hashimoto et al. [64] developed a novel 3D system  
using murine macrophages (RAW 264.7 cell line) to assess the biological effects of  
polyvinylpyrrolidone-coated silver NPs. The authors observed that the cytotoxic results differ between 
2D and 3D cultures, the 3D culture system being less sensitive to the NP cytotoxic effects.  
In another study, a 3D in vitro model was proposed to evaluate the potential of carbon nanotubes to 
form epithelioid granulomas in nonadherent primary murine bone marrow-derived macrophages 
(BMDM), cultures in a 3D system [65]. The results of this study showed the distinctive morphological 
and phenotypic responses of the 3D culture, which suggest this in vitro model as a potential alternative 
to both traditional 2D monolayer cultures and to rodent bioassays for granuloma formation (Figure 1). 
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Figure 1. Light microscopic morphology and kinetics of macrophage aggregation in 2D 
and 3D cultures. BMDM were exposed to 0.5 μg/mL (0.38 μg/cm2) of particulates. 
Formation of stable cellular aggregates was evaluated at 3 and 14 days post-exposure. 
Macrophages were stained with May-Grünwald-Giemsa. Reprinted from [65]. Open Access 
article, under the terms of Creative Commons Attribution License. Copyright 2011, 
Licensee Biomed Central Ltd.  
 
The 3D cell culture systems have also been applied as a useful tumor model to study the antitumor 
activity of a wide range of NMs. 3D-tissue-engineered tumor models have the potential to bridge the 
gap between monolayer cultures and patient-derived xenografts and, in this context, were applied to 
test different NP-based chemotherapeutics [66–68]. Xu et al. [69] developed a hydrogel-derived 
prostate cancer model, in which the cancer cells were entrapped in hyaluronic acid matrices to form 
distinct tumor-like multicellular aggregates. Finally, the application of 3D in vitro models to study the 
advantages of nanotechnology for cancer therapy has been recently reviewed [70]. 
2.2. Alterations of Enzymatic Activity 
Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are important enzymes in the area 
of neurobiology, toxicology and pharmacology. Inhibition of AChE causes the accumulation of 
acetylcholine, interfering with the function of the nervous system. On the other hand, inhibition of 
BChE could result in the accumulation of acetylcholine in neural synapses, which can disrupt the 
nervous system normal function. In a recent study, it was demonstrated that silver NPs inhibited both 
the activity of AChE and BChE in vitro, by using an enzyme assay with o-nitrophenyl acetate or  
o-nitrophenyl butyrate as substrates, respectively [71]. The extent of ChEs inhibition was shown to be 
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dependent on the surface coating of silver NPs, and these preliminary findings suggest that metallic 
NPs had an inhibitory potential on the metabolism of xenobiotics governed by the cholinesterases. 
Finally, the authors stated that the tested enzyme assays offer practical implementation in the 
toxicokinetic studies of metallic NPs. 
The adsorption and inhibition of AChE [72] and BChe [73] by different NMs, including three metal 
NPs (Cu–C, Cu and Al), three oxides NPs (SiO2, TiO2 and Al2O3) and two carbon nanotubes 
(MWCNT and SWCNT) have been assessed. In these experiments, the Ellman assay [74] was used to 
measure the activity of both enzymes and calculate the inhibition rate, because NPs could adsorb the 
yellowish product, 50-mercapto-20-nitrobenzoic acid (5-MNBA) during the color development, which 
does not allow a simple colorimetric enzyme activity assay. The samples were finally read at 410 nm 
by spectrophotometry. 
The effects of different classes of NPs on the enzymatic activity of the cytosolic protein human 
arylamine N-acetyltransferase 1 (NAT1) was recently investigated [75]. The importance of NAT1  
lies in the fact that it is a drug-metabolizing enzyme responsible for the activation and detoxification of 
known carcinogens. NMs including metal oxides, synthetic clay NPs and a self-assembling  
thermo-responsive polymeric NP that differ in size and surface characteristics were used to perform 
the study. The results suggested that enzyme activity may be compromised in organs exposed to NPs 
and, thereby highlighting the importance of the evaluation of NP–enzyme interactions. 
The binding of luciferase with citrated-coated silver NPs was studied by Kakinen et al. [76]. It was 
demonstrated that luciferase readily bound to NPs through electrostatic interactions and, thus, the 
authors analyzed whether the enzyme activity was hindered as a result of the interaction by using 
different analytical techniques such as UV-vis spectrophotometry, transmission electron microscopy, 
circular dichroism (CD) spectroscopy and inductively coupled plasma mass spectrometry. The 
combination of these mechanistic studies may give the basis for facilitating the understanding of NM 
implications at the molecular level. 
Polyamidoamine dendrimers with different surface charges (positive, negative and neutral) were 
studied in respect to their ability to interact with porcine pepsin, a negatively charged protein [77]. The 
enzymatic activity of pepsin was measured by UV spectrophotometry, followed by CD spectroscopy 
analysis. The dendrimers with positive and neutral surface charges were able to inhibit enzymatic 
activity, whereas the negatively charged dendrimer had no influence on the activity of pepsin, probably 
due to the electrostatic repulsion. 
On the other hand, novel polymeric NPs with mucoadhesion and enzymatic inhibition activity were 
developed for transnasal insulin delivery [78]. The inhibitory activity of these NPs toward  
α-chymotrypsin, elastase, trypsin and leucine aminopeptidase was tested. The NPs were incubated with 
substrate solutions and the progress of reaction was followed by monitoring the appearance of the 
absorption band of p-nitroaniline at 410 nm by UV-Vis spectrophotometry. The tested NPs showed 
strong inhibitory activity especially toward leucine aminopeptidase present on the nasal mucosa, which 
demonstrated their potential application as novel drug delivery systems for transnasal delivery of 
protein and peptide drugs. 
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2.3. Alterations on the Normal Cell Cycle 
Assessment of alterations in the cell cycle has been commonly performed using a fluorescent 
solution of propidium iodide (PI) and flow cytometry analysis. Apart from the utilization of a PI 
solution, the cells were incubated with the enzyme RNaseA before flow cytometry analysis.  
Chuang et al. [47] and Paul et al. [34] evaluated the effects of gold NPs and PLGA NPs on normal cell 
cycle, respectively, by using this approach. Moreover, Darolles et al. [52] assessed the effects of cobalt 
oxide particles on the normal cell cycle of BEAS-2B human bronchial epithelial cell line.  
Staining the DNA with PI, followed by flow cytometry analysis, was also used to perform the cell 
cycle analysis of A549 cells after treatment with silver NPs [79]. Ten thousand cells were analyzed, 
and the percentage of the cells in the sub-G1 phase of the cell cycle was calculated from the total 
10,000 cells (100%) in the assay, while the percentages for cells in the G0/G1, S and G2/M phases 
were calculated from the total cells excluding the sub-G1 cells. 
2.4. Induction of Apoptosis and Necrosis 
The fluorescein isothiocyanate (FITC)-annexin V and PI-annexin V double-staining methods have 
been widely used to detected apoptosis induced by a variety of NMs. These approaches are based on 
the determination of phosphotidylserine externalization during apoptosis and leakage from necrotic 
cells. The ratio of apoptotic and necrotic cells after exposure to silica NPs was measured with the 
annexin V/PI assay by Foldbjerg et al. [45]. This approach analyzed the cells at different stages, i.e., 
early apoptosis (annexin V+, PI−), late apoptosis/necrosis (annexin V+, PI+) and live (annexin V−, PI−) 
cells. Alternatively, apoptotic cell death prompted by gold NPs [40,47], photocopiers emitting NP [80] 
and food-relevant inorganic NPs [81] were determined using annexin V-FITC binding assays. 
McCracken et al. [81] also performed a specific assay to evaluate necrotic cell death (cellular 
membrane damage) in NP-treated cells. The authors performed a flow cytometric analysis using Sytox 
Red dead cell stain. As a positive control for cell death, some cells were treated with 10 or 20 mM 
hydrogen peroxide. 
Another double-staining method for apoptosis study is based on the use of the fluorescent dyes 
acridine orange (AO) and ethidium bromide (EB). By this approach, the treated cells were analyzed by 
fluorescence microscopy. Nogueira et al. [7,20] used this assay to assess the apoptotic and necrotic 
potential of pH-sensitive polymeric NPs and nanovesicles, respectively, in both tumor and non-tumor 
cell lines. Moreover, A549 cells were double stained with AO/EB after treatment with plant  
latex- capped silver NPs, and their apoptotic potential examined under a fluorescence microscope [82]. 
Western blot analysis was used to determine if exposure to gold NPs induced expression of various 
proapoptotic-related proteins [33]. By this assay, procaspase-9, one of thelate apoptosis-initiating proteins 
of the intrinsic pathway, was analyzed, along with the effector poly (ADP-ribose) polymerase (PARP), a 
DNA repair enzyme commonly cleaved as a result of caspase-3 and caspase-7 activation. Alternatively, 
immunofluorescence detection of activated caspase-3 was performed in order to detect the apoptotic 
pathway of A549 cells after incubation with engineered cadmium-coated silica NPs [56]. The cell 
samples were incubated with specific antibodies and were counterstained for DNA with PI, and finally 
examined under a fluorescence microscope.  
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Propidium iodide, a fluorescent DNA intercalating agent, has been used to stain and quantify the 
proportion of cells in the sub-G1 phase of the cell cycle, which is indicative of apoptotic cells.  
This assay was used by Coulter et al. [33] in order to determine the apoptotic potential of gold NPs and 
thus to confirm the expression of various proapoptotic proteins previously detected by Western  
blot analysis. 
Paul et al. [34] used various approaches to determine the apoptotic potential of biodegradable 
poly(lactide-co-glycolide) (PLGA) NPs. Different methods based on cellular morphology analysis 
under phase contrast microscopy, nucleosomal fragmentation study with DAPI staining and analysis 
under fluorescence microscopy, and more specifically on AO/EB and annexin V-FITC/PI double 
staining, were considered for a detailed characterization of apoptosis (Figure 2). Moreover, change in 
expression of some key apoptotic genes in both mRNA and protein levels, i.e., p53, Bax, Apaf-1, 
cytochrome c, caspase-9, caspase-3 and Bcl-2, was determine by immunoblot analysis. 
Figure 2. (A) Morphological changes of nano-chelidonines (NCs) (10 and 20 µg/mL)-treated 
HepG2 cells observed by phase contrast microscope; (B) nuclear condensation assessment of 
control and treated cells by DAPI staining were analyzed through fluorescence microscopy;  
(C) the increased apoptotic cells were determined by AO/EB staining through fluorescence 
microscopy. The nuclear condensation and transformation of color green to reddish orange with 
fragmented nuclear membrane represents the induction of apoptosis in the treated cells with 
respect to control ones; (D) assessment of cellular apoptosis by externalizing phosphatidyl serine 
through Annexin V/PI assay by flow-cytometric analysis. Reprinted with permission from [34]. 
Copyright 2013, Elsevier.  
 
Finally, a cell death detection enzyme-linked immunosorbent assay (ELISA) kit was used to 
differentiate late apoptosis from necrosis after incubation of J774A.1 mouse macrophages with 
chromium oxide NPs [83]. The specific enrichment of mono- and oligo-nucleosomes in cell lysates 
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(reflecting the level of late apoptosis), and in culture supernatants (reflecting the level of necrosis), was 
presented as an enrichment factor for each experimental condition. 
2.5. Induction of Oxidative Stress 
Nanomaterial-induced reactive oxygen species (ROS) play a key role in cellular and tissue toxicity. 
The intracellular ROS production by NM can follow two different pathways: direct ROS generation 
through NM-catalyzed free-radical reactions in cells, or indirect ROS generation through disturbing  
the inherent biochemical equilibrium in cells [84]. Because of these different mechanisms, some  
cell-based assays seek to quantify the ROS species production by cells directly, while others seek to 
quantify its effects on cell behavior or further production of other cell biochemical reactions. 
The intracellular generation of ROS after NM exposure was commonly measured by using the 
fluorescent marker 2,7-dichlorodihydrofluorescin diacetate (DCFH-DA). DCFH-DA passively enters 
the cell where it reacts with ROS to form the highly fluorescent compound dichlorofluorescein (DCF). 
This DCF assay was used to assess the generation of ROS after treatment with different kinds of 
bovine serum albumin (BSA)-stabilized silica NPs [45] (Figure 3) and of multi-walled carbon 
nanotubes (MWCNTs) [51], being the cells analyzed by flow cytometry. On the other hand, cell 
fluorescence was analyzed by fluorimetry to detect ROS production after treatment with silver  
NPs [53] and CB, single-wall carbon nanotube, SiO2 and ZnO NPs [19]. Likewise, the derivative 
fluorescent probe 5-6-chloromethyl- 2′7′-dichlorodihydrofluorescein diacetate acetyl ester was applied 
to measure ROS level after cell incubation with gold NPs [33]. 
Figure 3. Measurement of ROS production in A549 cells after 24 h NP exposure. The 
DCF fluorescence of treated cells was normalized to that of untreated controls and reported 
as mean ± SD. Reprinted with permission from [45]. Copyright 2013, Elsevier. 
 
Alternatively, ROS production after cell exposure to NMs has been assessed with the fluorescent 
probe dihydroethidium (DHE). DHE assay is able to detect superoxide radicals. In cells, DHE reacts 
with superoxide anion to form ethidium, which exhibits red fluorescence. This assay was applied to 
determine the dependence of oxidative stress on the size of silica NPs [85] and to assess whether local 
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ROS contribute to impair endothelium-dependent vasodilatation in coronary arterioles after  
NP inhalation [86]. 
As a more specific assay to detect intracellular peroxide formation, Shen et al. [87] used the 
MitoSOX Red-based assay to evaluate the mitochondrial superoxide levels as a measure of oxidative 
stress and intracellular ROS generation. Mitochondria are a major intracellular source of ROS and, 
thus this assay appears to be more specific and sensitive.  
Yang et al. [19] also used the intracellular glutathione (GSH), superoxide dismutase (SOD) activity 
and malondialdehyde (MDA) measurement to indicate the oxidative damage caused by CB,  
single-wall carbon nanotube, SiO2 and ZnO NPs. The concentration of intracellular GSH, determined 
by colorimetric assay, was also used by De Simone et al. [56] to evaluate the oxidative stress induced 
by cadmium-coated silica NPs. Alternatively, GSH depletion induced by silver NPs in HepG2 cells 
was evaluated through luminescence measurement using a plate reader [88]. 
In another study, despite the measurement of intracellular GSH, it was performed specific assays to 
determine the activities of glutathione reductase (GR) and glutathione peroxidase (GPx), two crucial 
enzymes involved in GSH metabolism [89]. The results of each assay were obtained through 
spectrophotometric readings.  
The measurement of reactive nitrogen species (RNS) have also been used to determine oxidative 
stress induced by NMs. Roy et al. [90] applied this assay to measure the RNS generation after 
machophages incubation with ZnO NPs. After a defined incubation time, RNS was measured by using 
Griess’s reagent and absorbance was measured at 540 nm in a plate reader. 
Superoxide anion production induced by plant latex-capped silver NPs was evaluated by nitro blue 
tetrazolium (NBT) reduction method [82]. The results were obtained after absorbance readings at 570 nm. 
The reaction of malondialdehyde (MDA) with thiobarbituric acid (TBA) has been applied to 
determine the lipid peroxidation elicited by ROS. It is known that cell surface and organelle membrane 
lipids may undergo peroxidation in response to oxidative stress [91]. In this line, the oxidative damage 
induced by nanovesicles containing pH-sensitive surfactants was studied by using this simple 
approach, being the responses measured using a microplate reader at 532 nm [20]. The measurement of 
MDA was also used by Tang et al. [92] to determine the oxidative stress induced by nanosized 
titanium dioxide. 
2.6. Induction of Injury in Specific Cell Organelles: Mitochondria and Lysosome 
2.6.1. Mitochondrial Injury 
The mitochondrial injury has been commonly evaluated by the rhodamine 123 (R123) assay,  
which is based on fluorometric readings of cell responses after incubation with the NMs under test. 
Sahu et al. [53] used this approach to assess the induction of any damage to the mitochondria after cell 
treatment with silver NPs. The uptake and retention of the fluorescent dye R123 by viable living cells 
is directly proportional to their mitochondria membrane potential [93] and thus any injury in the 
mitochondrial compartment will be detected by alteration in this potential.  
This same approach was used to assess the effect of TiO2 NPs on the mitochondrial integrity, the 
cells being re-suspended in PBS containing 25 mM rhodamine 123 after each NP treatment [37]. 
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Whereas many authors use the ATP luminescence assay to detect NM cytotoxicity, Tang et al. [92] 
applied this assay as a measure of mitochondrial integrity. Intracellular ATP level is a sensitive readout 
of the mitochondrial state and was determined using a firefly luciferase-based ATP assay. 
Tetramethyl rhodamine ethyl ester (TMRE) assay has been applied to measure the mitochondrial 
membrane potential (MMP) after NM treatment. Chairuangkitti et al. [79] evaluated the changes in the 
MMP after silver NPs exposure by using the TMRE assay. TMRE is a red–orange fluorescent 
permeable cationic and lipophilic dye, which can be readily taken up by active mitochondria into the 
negatively charged mitochondrial matrix. Thus, the intensity of the fluorescent signal obtained is 
indicative of the MMP. In another study, changes in the MNP, after cell incubation with titanium 
dioxide NPs, were measured using the lipophilic cationic dye, 3,3′-dihexyloxacarbocyanine (DiOC6), 
with cell analysis performed by flow cytometry [94]. 
2.6.2. Lysosomal Injury 
The integrity of the lysosomal membrane after cell treatment with pH-sensitive chitosan NPs 
encapsulating methotrexate (MTX) has been assessed using the acridine orange (AO) relocation 
technique [7]. AO is a lysosomotropic base that produces a red fluorescent emission when accumulated 
in acidic lysosomes, and the disruption of the lysosomal membrane can be assessed by measuring the 
change in intracellular AO fluorescence (i.e., the loss of the lysosomal red signal and gain of 
cytoplasmic green) (Figure 4). Following the treatment with NPs, the cells were stained with the dye 
and analyzed under fluorescence microscopy.  
Figure 4. Assessment of the effects of chitosan NPs encapsulating MTX (MTX-CS-NPs) 
on lysosomal membrane permeabilization in HeLa cells as visualized via AO staining. In 
untreated control cells, lysosomes can be seen as red–orange granules and cytoplasm has a 
diffuse green fluorescence. In cells with lysosomal membrane damage (HeLa cells treated 
with 50 mg/mL MTX-CS-NPs), lysosomes exhibit a shift from red–orange to a yellow–green 
fluorescent color. Reprinted with permission from [7]. Copyright 2013, Elsevier. 
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Sohaebuddin et al. [95] also applied this same assay to determine the effects of TiO2 and SiO2 NPs, and 
multi-wall carbon nanotubes (MWCNTs) with differing sizes, on lysosomal membrane integrity of 
three established cell lines. In another study, the effect of the polystyrene nanosphere on lysosomal 
stability was determined by using AO staining, but with cell analysis performed by flow cytometry [41]. 
Alternatively, Fröhlich et al. [96] used lucifer yellow to assess the lysosomal integrity after cell 
exposure to polystyrene NPs of different sizes, the results being obtained after analysis by confocal 
laser scanning microscopy. Moreover, the authors used an acidotropic probe that accumulates in acidic 
compartments of cells as a result of protonization to assess the lysosome function/pH. Accumulation in 
the acidic environment of lysosomes results in a pH-dependent increase in fluorescence, which was 
quantified by confocal laser scanning microscopy. Finally, the lysosome function was also assessed by 
measuring the activity of lysosomal enzymes cathepsin B and sulfatases through fluorometry. 
2.7. Induction of DNA Damage and Genotoxicity 
The alkaline single-cell gel electrophoresis (comet) assay has been used to study DNA strand breaks 
and alkaline labile sites in different cell lines after NM treatment. This assay was performed to assess 
the genotoxicity potential of different types of NMs, including CB, single-wall carbon nanotube, SiO2 
and ZnO NPs [19]. Moreover, Khatri et al. [80] used this assay to assess the DNA damage prompted 
by photocopiers emittinh NPs, while Ghosh et al. [37] monitored the DNA damage in human 
lymphocytes incubated with TiO2 NPs (Figure 5), and Nogueira et al. [20] assessed the genotoxic 
potential of pH-sensitive lipid-based nanovesicles. 
Figure 5. Comet data (% tail DNA) of human lymphocytes treated with different 
concentrations of titanium dioxide (TiO2) nanoparticle; * P < 0.05. Reprinted with 
permission from [37]. Copyright 2013, John Wiley and Sons.  
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Cellular DNA damage induced by silver NPs was determined fluorometrically by the  
cellular double-stranded DNA (ds-DNA) content. In this assay, the nonfluorescent dye Hoechst 33258 
becomes highly fluorescent when it binds to the ds-DNA, the ds-DNA content being determined from 
a standard plot [53]. 
Genotoxicity of PVP-coated silver NPs in BEAS 2B cells was assessed by three different approaches: 
the alkaline comet assay, the chromosomal aberration (CA) assay, and the cytokinesis-block micronucleus 
(CBMN) assay [48], which can be used to study chromosomal damage that occurs due to exposure to 
toxic agents.  
The in vitro DNA damage induction by short multi- and single-wall carbon nanotubes was assessed 
by comet assay, by the CBMN assay and also by using the immunoslot blot assay for the detection of 
malondialdehyde (M1dG) DNA adducts [97].  
Finally, detection of genotoxicity induced by mesoporous silicon NPs was made using the BrdU  
(5-bromo-20-deoxyuridine) ELISA-based assay [98]. The results were obtained after absorbance 
measuring using a microplate reader at a wavelength of 450 nm. 
2.8. Inflammatory Responses 
Enzyme-linked immunosorbent assay (ELISA) is the main method used to measure the 
inflammatory responses of different kinds of NMs. The conditioned medium of HSCs cells treated 
with silver NPs were analyzed using ELISA for the presence of different mediators, such as hepatocyte 
growth factor (HGF), interleukin (IL)-6, transforming growth factor (TGF)-β1, tumor necrosis factor 
(TNF)-α, matrix metallopeptise (MMP)-2 and MMP-9 [46]. An ELISA kit was also used to quantify 
the levels of the proinflammatory IL-8 after cell treatment with ZnO NPs [99]. 
The measurement of enhancement in secretions of cytokines, in particular proinflammatory 
cytokines, following the incubation of cells with NPs coated with either non-ionic poly(ethylene 
glycol) or zwitterionic poly(carboxybetaine), was performed by using a multiplex assay that monitor 
the expression of several cytokines, including interleukin (IL)-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, 
IL-9, IL-10, IL-12 (P40), IL-12 (P70), IL-13, IL-17, granulocyte-colony-stimulating factor(G-CSF), 
granulocyte macrophage-colony-stimulating factor (GM-CSF), interferon-γ (IFN-γ) and tumor necrosis 
factor-α (TNF- α) [100]. Likewise, a multiplex assay was used to assess the release of 13 cytokines 
(IL-8, G-CSF, IL-1α, IL-1β, IL-6, IFNγ, and others) after THP-1 cells treatment with photocopiers 
emitting NPs [80]. 
In another study, cytokines such as IL-12, TNF-α, IL-10, IL-6, IL-1β and IL-8 were measured by a 
cytometric beads array set system, the samples being incubated with antibodies for fluorescence 
detection and analyzed by flow cytometry [51]. This assay was applied to assess the inflammatory 
response induced by multi-walled carbon nanotubes. Likewise, Roy et al. [90] used this approach to 
measure IL-6, IL-10, IL-17, TNF-α and IFN-γ release after cell treatment with ZnO NPs.  
Moreover, these same authors also examined the role of proteins opsonization of ZnO NPs with  
IgG in phagocytosis. With this intend, fetal bovine serum (FBS) opsonized particles (ZnO NPs 
disperse in 10% FBS-supplemented RPMI (Roswell Park Memorial Institute) media) were incubated 
with IgG and its binding was measured by ELISA. 
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Lastly, elastase release assay was also used to measure inflammation because activated  
neutrophils degranulate to release inflammatory mediators such as elastase. This assay was applied to 
evaluate the response of human neutrophil after exposure to cationic surfactants in the form of NPs and 
micelles [50].  
2.9. Interactions with Blood Components 
Hemolysis and agglutination assays using EDTA-stabilized rat blood were performed to determine 
the hemocompatibility of lipid nanovesicles modified with cationic lysine-based pH-sensitive 
surfactants [20]. For the typical hemolysis assay, the samples were incubated with erythrocyte 
suspension, the measure of cell damage and hemoglobin release having been performed by 
spectrophotometry. On the other hand, the agglutination was determined by phase contrast microscopy. 
In this same study, the authors also analyzed the adsorption of human plasma proteins to the surface of 
the nanocarriers. For this purpose, sodium dodecyl sulfate polyacrylamide gel electrophoresis  
(SDS-PAGE) analysis was performed. These same hemolysis and agglutination assays were also used 
by the authors to determine the blood compatibility of chitosan NPs modified with a pH-sensitive 
lysine-based anionic surfactant [7]. 
Hemolysis assay was also employed to evaluate the in vitro blood compatibility of GO and GS 
intended for biomedical applications, using fresh ethylenediaminetetraacetic acid (EDTA)-stabilized 
human whole blood samples [38]. Recently, Shahbazi et al. [98] performed the hemolysis assay using 
human erythrocytes to study the hemocompatibility of mesoporous silicon NPs. Moreover, to evaluate 
the morphological changes and also the NP–erythrocyte interactions, the diluted erythrocyte 
suspension were evaluated by scanning electron microscopy (SEM) after incubation with NPs.  
An extended study on the effects of TiO2 NPs on peripheral blood has been performed by  
Ghosh et al. [37]. Human peripheral blood cells were incubated with different concentrations of NPs 
and blood count tests were performed using a hematology analyzer to determine, among other 
parameters, the white and red blood cell count, hemoglobin, hematocrit value, platelet count, 
neutrophils, lymphocyte, monocyte, eosinophil, basophil and reticulocytes. 
It is known that NPs are subject to the inspection of the immune system and, the complement 
system is a rapid-acting host defense mechanism that protects the intravascular space and other 
biological compartments from foreign attackers [101]. In this context, Pham et al. [102] employed a 
modified in vitro hemolysis-based assay to examine the variations in NP-mediated complement 
activity between individuals. The assay was applied to perfluorocarbon NPs of varying size, charge 
and surface chemistry, and might provide the tools for an in-depth structure–activity relationship study. 
Hyperbranched polyglycerol hybrid nanostructures were tested for their probable effects on blood 
coagulation time by using Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT) 
tests, the blood biocompatibility of NMs being measured by means of a coagulation analyzer with 
mechanical end point determination [103]. Moreover, the complement activation was evaluated using a 
commercial single radial immuno-diffusion (SRID) immunoassay kit, which monitors the cleavage of 
complement components C3 and C4.  
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3. Nanomaterials Characterization Needed for Reliable Nanotoxicological Assessment  
In vitro nanotoxicology has many advantages (as already described in Section 2), but also presents 
special problems that are directly related to the specific characteristics and physicochemical properties 
of NMs. Not everything called nano is actually nano, because secondary structures with significantly 
higher sizes are formed due to NP agglomeration or aggregation in aqueous media [104]. Nanoparticle 
size is a significant parameter to evaluate, not only in determining the release profile and degradation 
manners, but also in determining the efficacy of the therapeutic agent in terms of tissue penetration and 
cellular uptake [105]. This is only one example that highlights the importance of a detailed 
physicochemical characterization before the performance of any in vitro study. Structural alterations of 
NPs in aqueous solutions, i.e., in cell-culture medium, might also affect and change the final results of 
the in vitro toxicological studies. Likewise, the surface charge of NPs plays an especially important 
role in cell–NP interactions because cell membranes themselves are charged [38]. Understanding the 
behavior of NMs at the time of toxicological assay may play a crucial role in the interpretation of its 
results [106]. Finally, the results obtained from studies in which the NM characterization was not 
properly performed might be very controversial, making difficult the gain of conclusive data and the 
elucidation of the main mechanisms underlying toxicity.  
Nanoparticles with similar chemical compositions may have totally different sizes, shapes, crystal 
structures, surface coatings, and surface reactivity characteristics, thereby creating a quite difficult 
situation for analysis by chemists, medical scientists and toxicologists [10]. Therefore, a detailed and 
comprehensive physicochemical characterization of the test NMs is stated as the first step before any 
toxicological screening [2,15]. 
A testing system to assess NM toxicity has been suggested [23,29]. Different stages are described, 
including an emphasis on detailed physicochemical characterization prior to and during subsequent 
testing in cell-free, in vitro cell-based and in vivo assays. The careful evaluation of NM solubility,  
chem-reactivity, size, hydrodynamic diameter, agglomeration/aggregation, zeta potential and polydispersity 
is recommended.  
The unique physiochemical properties of NMs might represent major problems during in vitro 
assays. Even the utilization of well-established in vitro models can lead to false-positive or false-negative 
results, as well confounding or conflicting data. Furthermore, the properties of NMs, such as nanosize, 
high absorption capacity, catalytic activity, magnetic properties, dissolution and alkalinity/acidity, 
might introduce substances into cytotoxicity studies, which could interfere with assay components or 
detection systems [107]. Taken together, these unique characteristics of NMs must be considered for 
their in vitro toxicological evaluation. Because of the predicted variability and inconclusive data, a 
combination of different techniques and endpoint assays might be required in order to achieve more 
reliable data about NM risk assessment.  
A suitable characterization of NMs, either in the original dispersion or when suspended in cell 
culture media, is needed prior to any in vitro assay in order to achieve detailed knowledge concerning 
general and specific bio–nano interactions. Size characterization can be performed by scanning 
electron microscopy (SEM) [108,109] or transmission electron microscopy (TEM) [31,48,110]. 
Dynamic light scattering (DLS) is widely used to determine the hydrodynamic diameter and the 
polidispersity of NM suspensions [20,111]. Other less conventional methods have also been applied to 
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size characterization of NMs. Helfrich et al. [112] developed a reliable method for the size 
characterization of gold NPs by using liquid chromatography coupled on-line to inductively coupled 
plasma–mass spectrometry (ICP-MS). Surface morphology and particle size of the NPs can be also 
determined by atomic force microscopy (AFM), as described by Paul et al. [34] to characterize PLGA 
NPs. Liao et al. [38] also used AFM to measure the particle size of graphene sheets (GS) and graphene 
oxide (GO). 
Izak-Nau et al. [106] performed a detailed characterization of silica NPs by assessing their colloidal 
stability in water, standard biological buffers, and cell culture media containing either bovine or human 
sera. Techniques such as DLS, zeta potential measurements and TEM have also been used. Moreover, 
interactions of the particles with biological media were investigated by SDS-PAGE in bovine and human 
sera, and extracted proteins were assessed using matrix-assisted laser desorption/ionization-time of 
flight technique (MALDI-TOF). The authors demonstrated that the NPs tended to agglomerate, and 
that this phenomenon depended on NP functionalization as well as on their concentration and the 
incubation time. Altogether, the results of this study showed that the surface charge, ionic strength and 
biological molecules alter the properties of NPs and potentially affect their resulting biological effects. 
For the polymeric NPs, Fourier transform infrared (FTIR) spectroscopic studies to ascertain 
whether the encapsulation procedure altered the characteristics of polymer or drug, and whether 
interactions occur between the drug and the polymer after encapsulation is very commonly applied. 
Furthermore, FTIR data also speak about whether appropriate polymerization had occurred or whether 
monomers were present in the physical mixture. Among many authors, Paul et al. [34] characterized 
chelidonine-loaded PLGA NPs by using this analytical approach. Likewise, attenuated total 
reflectance-FTIR spectroscopy has been applied to evaluate the attachment of a reducing and 
stabilizing agent to silver NPs [98]. Moreover, in this same study, the kinetics of thermal decomposition 
of the nanocomposites was investigated using different heating rate thermo-gravimetric analysis.  
More specifically, information about the molecular structure and chemical speciation can be 
obtained using techniques such as synchrotron radiation circular dichroism spectroscopy (SRCD) and 
X-ray absorption fine structure (XAFS), respectively [10]. X-ray photoelectron spectroscopy (XPS) 
was also used to measure the chemical composition of NMs such as GO and GS [38]. Moreover, 
Raman spectroscopy is a noninvasive technique that can be applied for the characterization of 
structural and electronic properties of NMs [113,114]. 
Information concerning the specific surface area per mass unit (m2·g−1) has been obtained by means 
of Brunauer, Emmet and Teller (BET) analysis (adsorption of nitrogen in cryogenic condition). The 
surface area is an important type of metric to be considered during toxicological studies and, thus, the 
BET analysis has been applied to characterize NMs such as silica NPs [115], nanoclusters of poorly 
soluble drugs [116], and calcium carbonate NPs [117]. 
4. Relationships between Cell Internalization of Nanomaterials and Their  
Toxicological Responses 
The varied NM–cellular localization and interaction might lead to varied modes of toxicity. Even 
NPs of the same material can show completely different intracellular behavior due to, for example, 
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slight differences in surface coating, charge and size. It has been reported that especially the NM size 
determines the efficiency of cellular uptake and subsequent intracellular processing [118]. 
Cellular uptake and localization of NPs will almost certainly be different than internalization of 
molecular species, and this fact will likely lead to different modes of toxicity. While there are some 
examples in the literature exploring NP uptake and localization, this is currently far from being well 
understood and, evidently varies significantly based on the NP being used. In order to obtain more 
reliable data concerning cellular uptake and localization, a number of imaging methods are available to 
greatly advance the understanding of NM behavior in the cellular compartments. 
Not only the cell internalization, but also the disruption of the NM inside the cell greatly influences 
the resulting toxic effects. The cytotoxicity could be attributed to the chemical composition of the 
nanostructure, but it should be considered that the NM destabilization results in release of its content 
into intracellular compartments, which can present synergic cytotoxic effects. This cytotoxicity can be 
desired, i.e., in antitumor treatments [7,119,120], or undesired, i.e., during NM application for 
diagnostics purposes [121,122]. 
The internalization efficiency of NMs is commonly assessed by using flow cytometry and/or 
fluorescent microscopy. For this purpose, a range of different dyes have been using in order to control 
and/or visualize the intracellular trafficking and final localization of NPs. Rhodamine [123], FITC [41] 
and acridine orange [124] are molecules usually used as fluorescent markers in this kind of study. 
Considering the drugs with autofluorescent behavior, doxorubicin is the most commonly used as 
model molecule [125,126]. 
When the NM is designed for an intended release of its content inside the cell in order to achieve 
therapeutic effects, one common strategy is to exploit the intracellular pH gradients [127]. Fluorescent 
dyes and drugs are frequently used as markers for cell uptake and intracellular behavior studies. 
Among fluorescent dyes, calcein has been widely applied as a tracer molecule, which is internalized by 
the cell through endocytosis and is thus used to monitor the stability of endosomes following NM 
uptake [7,20].  
Cellular visualization of NPs can be assessed through analytical approaches such as fluorescence 
microscopy, flow cytometry, confocal laser scanning microscopy (CLSM), transmission electron 
microscopy (TEM), soft X-ray scanning transmission microscopy (STXM), X-ray fluorescence  
(μ-XRF) and X-ray absorption near edge structure (μ-XANES) [10]. Additionally, Ng et al. [128] 
demonstrated the applicability of Energy-Dispersive X-ray (EDX) spectroscopy to reveal cellular 
uptake of gold NPs and their aggregate forms. Likewise, inductively coupled optical emission 
spectrometry (ICP-OES) was used to determine the cellular uptake of cadmium NPs in renal cells [36]. 
Moreover, inductively coupled plasma–mass spectrometer (ICP-MS) has been applied to measure the 
intracellular content of silver NPs [88]. 
5. Conclusions 
Nanotechnology is considered a technology of the future, with especially important potential 
applications in the biomedical sciences. Nanotechnology, nanomedicine and nanotoxicology are 
complementary fields that in conjunction aim to improve human life. The discipline of nanotoxicology 
aims to study how properties of NMs define their interactions with cells, tissues and organs in exposed 
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humans. In this context, understanding NM behavior in live biological systems is of increasing 
importance for determining their potential toxicity. 
The need for more toxicological information concerning the risks of exposure to nano-based 
structures is reflected in the growing number of studies leaning toward the evaluation of NM toxicity 
and elucidation of the mechanisms underlying these hazardous effects to environmental and human 
health. The in vitro cell-based approaches are more attractive for NM testing, especially due to ethical 
aspects and the expense of animal testing. Therefore, relevant in vitro toxicological models based on 
established cell lines have become the basis of a highly needed screening approach and high-throughput 
toxicity testing protocols essential for the preliminary risk assessment of NMs. In line with the in vitro 
toxicology, it is worth mentioning that all toxicity data must be interpreted in the context of the 
physicochemical characteristics of the nano-sized materials, in order to assure the reliability of the 
obtained data, and also to possibly establish a structure–toxicity relationship.  
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